サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1696269

微生物培養の日本市場（2025年～2033年）

Japan Microbiology Culture Market - 2025-2033

出版日
ページ情報
英文 180 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
微生物培養の日本市場（2025年～2033年）
出版日: 2025年03月25日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の微生物培養の市場規模は、2024年に10億5,718万米ドルに達し、2033年までに21億8,582万米ドルに達すると予測され、予測期間の2025年～2033年にCAGRで8.5%の成長が見込まれます。

微生物培養は、微生物を培養して、その正体やサンプル中の個体数、あるいはその両方を調べる方法です。微生物学における主な診断方法の1つです。微生物培養を行うには、pH、大気ガス、温度、圧力が制御された適切な物理的環境が必要です。微生物培地の調製には、栄養素、緩衝剤、浸透圧バランス調整剤、選択的阻害薬または指示薬を混合し、微生物の増殖と分化をサポートする寒天またはブロスを作ることが含まれます。この工程は、腐敗微生物や病原微生物をモニタリングする微生物検査では日常的な作業です。

市場力学

促進要因と抑制要因

感染症の流行

感染症は、正確な病原体の同定、抗菌薬耐性検査、疾病監視が早期診断、治療、発生抑制に不可欠となることから、微生物培養技術に対する需要を増大させます。

日本における感染症の増加に伴い、先進の診断ツール、研究、治療開発の必要性が高まっています。細菌、ウイルス、真菌感染症の増加に伴い、医療提供者や研究機関は、病原体を正確に同定し、抗生物質耐性を判定し、効果的な治療戦略を開発するために、微生物培養への依存度を高めています。

日本ではマイコプラズマ肺炎の患者数が大幅に増加しており、過去10年間でこの時期の患者数がもっとも多くなっています。肺炎は日本における死因の第5位を占めています。例えば、日本の国立感染症研究所のデータによると、2024年10月までの1週間に報告されたマイコプラズマ肺炎の患者数は、全国で1医療機関あたり平均2.01人となり、初めて2人を超えました。このような感染症の増加により、培養装置や培養補助剤などの需要が増加することが予測されます。このように、感染症の増加は同国の市場成長を促進すると予測されます。

汚染のリスクと一貫性のない結果

汚染のリスクと一貫性のない結果は、微生物培養の正確性と信頼性に影響を与えることにより、日本の微生物培養市場の成長を妨げると予測されます。培養液の調製、保管、取り扱いにおける汚染は、誤った結果をもたらし、診断や調査の結果の質を低下させる可能性があります。一貫性のない信頼性の低い結果は、微生物検査の効率に影響を与えるだけでなく、誤診のリスクを高め、公衆衛生に深刻な影響を及ぼしかねません。これは治療の遅れ、抗生物質の不適切な使用、結果に対する信頼性の欠如につながり、最終的には医療従事者や研究者に懸念を抱かせることになります。

当レポートでは、日本の微生物培養市場について調査し、市場力学、地域とセグメントの分析、競合情勢、企業プロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 エグゼクティブインサイト、重要事項

  • 市場のハイライトと戦略的ポイント
  • 主要動向と将来の予測
  • 抜粋：製品タイプ別
  • 抜粋：培養タイプ別
  • 抜粋：一貫性別
  • 抜粋：用途別

第3章 市場力学

  • 影響要因
    • 促進要因
      • 感染症の流行
      • 微生物学と生命科学における研究開発投資の増加
    • 抑制要因
      • 培地生産に関する厳格な規制枠組み
      • 汚染のリスクと一貫性のない結果
    • 機会
      • 培養の困難な微生物に利用する革新的な培地の可能性
    • 影響の分析

第4章 戦略的考察と産業の見通し

  • マーケットリーダー、パイオニア
    • 新興パイオニアと著名企業
    • 最大の販売ブランドを持つ確立されたリーダー
    • 確立された製品を持つマーケットリーダー
  • CXOの視点
  • 最新の発展とブレークスルー
  • ケーススタディ/進行中の研究
  • 北米の規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大に対し推奨される戦略
  • シナリオ分析：ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第5章 微生物培養市場：製品タイプ別

  • 培養装置
    • バイオリアクター
      • バイオリアクターデバイス
      • 計測器具
      • PHセンサー
      • 溶存酸素センサー
      • 温度センサー
      • その他
      • 分析デバイス
      • セルカウンター
      • 分光計
      • その他
      • 滅菌装置
      • インキュベーター
      • その他
  • 培養サプリメント
  • 計測器具
    • PHセンサー
    • 温度センサー
    • 溶存酸素センサー
    • その他
  • 培養器具
    • ペトリ皿
    • ループ・針
    • マイクロピペット
    • 遠心分離機
    • その他
  • 分析デバイス
    • セルカウンター
    • 分光計
    • その他

第6章 微生物培養市場：培養タイプ別

  • 真核生物培養
  • 細菌培養

第7章 微生物培養市場：固さ別

  • 液体培地
  • 固体培地
  • 半固体培地

第8章 微生物培養市場：用途別

  • 医薬品
  • 食品・飲料産業
  • 水質検査
  • 化粧品

第9章 競合情勢と市場ポジショニング

  • 競合情勢の概要、主要市場企業
  • 市場シェア分析、ポジショニングマトリクス
  • 戦略的パートナーシップ、合併・買収
  • 製品ポートフォリオにおける主な発展、イノベーション
  • 企業ベンチマーク

第10章 企業プロファイル

  • Merck KGaA
  • Yokogawa Electric Corporation
  • SATAKE MultiMix Corporation
  • BEMARUBISHI CO., LTD.
  • ABLE Corporation & Biott Corporation
  • Eiken Chemical co. Lti.
  • BioMerieux SA
  • Thermo Fisher Scientific, Inc.
  • Sartorius AG
  • Kerry Group plc.

第11章 前提条件と調査手法

第12章 付録

目次
Product Code: BT9378

The Japan microbiology culture market reached US$ 1,057.18 million in 2024 and is expected to reach US$ 2,185.82 million by 2033, growing at a CAGR of 8.5% during the forecast period 2025-2033.

A microbiology culture, or microbial culture, is a method of growing a microbial organism to determine its identity, its abundance in a sample, or both. It is one of the primary diagnostic methods in microbiology. Growing a microbial culture requires an appropriate physical environment with controlled pH, atmospheric gases, temperature, and pressure. Microbial culture media preparation involves mixing nutrients, buffering agents, osmotic balance regulators, and selective inhibitors or indicators to create agar or broth that supports microbial growth and differentiation. This process is a routine task in microbiological testing for monitoring spoilage and pathogenic microbes.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Infectious Diseases

Infectious diseases increase the demand for microbiology culture technologies, as accurate pathogen identification, antimicrobial resistance testing, and disease surveillance become essential for early diagnosis, treatment, and outbreak control.

With the increasing number of infectious diseases in Japan there is an increasing need for advanced diagnostic tools, research, and treatment development. With the growing number of bacterial, viral, and fungal infections, healthcare providers and research institutions are relying more on microbiology cultures to accurately identify pathogens, determine antibiotic resistance, and develop effective treatment strategies.

Japan is experiencing a significant rise in mycoplasma pneumonia cases, with patient numbers reaching the highest levels for this time of year in the past decade. Pneumonia was the fifth leading cause of death in Japan. For instance, data from Japan's National Institute of Infectious Diseases showed that, for the week ending October 2024, an average of 2.01 cases per medical institution were reported nationwide, marking the first time this figure surpassed two cases per facility. This increase in the number of infectious diseases is expected to increase the demand for culture equipment, culture supplements, and other instruments. Thus, the increasing number of infectious diseases is expected to drive the country's market growth.

Risk of Contamination and Inconsistent Results

The risk of contamination and inconsistent results is expected to hinder the growth of the Japan microbiology culture market by affecting the accuracy and reliability of microbial cultures. Contamination during the preparation, storage, or handling of culture media can lead to false results, compromising the quality of diagnostics and research outcomes. Inconsistent or unreliable results not only impact the efficiency of microbiological testing but also increase the risk of misdiagnosis, which can have serious public health consequences. This can lead to delays in treatment, improper use of antibiotics, and a lack of confidence in the results, ultimately raising concerns among healthcare professionals and researchers.

Segment Analysis

The Japan microbiology culture Market is segmented based on the product type, culture type, consistency, and application.

Culture equipment in the product type segment is expected to dominate the microbiology culture market

Culture equipment in the product type segment is vital in the precise growth, isolation, and analysis of microorganisms. With the growing demand for advanced microbiological research, clinical diagnostics, and pharmaceutical development, the need for specialized culture equipment like incubators, autoclaves, and sterile handling instruments is becoming increasingly important.

Japan's advanced healthcare and biotechnology sectors require high-precision equipment to ensure the reliability of microbial culture processes. For various microbiology culturing and processing purposes, companies are introducing innovative microbiology culture solutions which is driving the segment's growth. For instance, in April 2023, Otsuka Techno Corporation, a subsidiary of Otsuka Pharmaceutical Factory, launched the OT-Algae, a resin-bag type microalgae culture device, as part of its environmentally friendly manufacturing efforts.

Competitive Landscape

The market players in the microbiology culture market are Merck KGaA, Yokogawa Electric Corporation, SATAKE MultiMix Corporation, B.E.MARUBISHI CO., LTD., ABLE Corporation & Biott Corporation, Eiken Chemical co. Lti., BioMerieux S.A., Thermo Fisher Scientific, Inc., Sartorius AG, and Kerry Group plc. among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan microbiology culture market report would provide approximately 42 tables, 33t figures, and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Culture Type
  • 2.5. Snippet by Consistency
  • 2.6. Snippet by Application

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Infectious Diseases
      • 3.1.1.2. Increasing R&D Investments in Microbiology and Life Sciences
    • 3.1.2. Restraints
      • 3.1.2.1. Stringent Regulatory Framework for Culture Media Production
      • 3.1.2.2. Risk of Contamination and Inconsistent Results
    • 3.1.3. Opportunity
      • 3.1.3.1. Potential for Innovative Culture Media for Fastidious Microorganisms
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. North America Regulatory and Reimbursement Landscape
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Microbiology Culture Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Culture Equipment*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Bioreactors
      • 5.2.3.1. Bioreactor Devices
      • 5.2.3.2. Measuring Instruments
      • 5.2.3.2.1. PH Sensors
      • 5.2.3.2.2. Dissolved Oxygen Sensors
      • 5.2.3.2.3. Temperature Sensors
      • 5.2.3.2.4. Others
      • 5.2.3.3. Analytical Devices
      • 5.2.3.3.1. Cell Counters
      • 5.2.3.3.2. Spectrometers
      • 5.2.3.3.3. Others
      • 5.2.3.4. Sterilization Equipment
      • 5.2.3.5. Incubators
      • 5.2.3.6. Others
  • 5.3. Culture Supplements
  • 5.4. Measuring Instruments
    • 5.4.1. PH Sensors
    • 5.4.2. Temperature Sensors
    • 5.4.3. Dissolved Oxygen Sensors
    • 5.4.4. Others
  • 5.5. Culture Instruments
    • 5.5.1. Petri Dishes
    • 5.5.2. Loops & Needles
    • 5.5.3. Micropipettes
    • 5.5.4. Centrifuge
    • 5.5.5. Others
  • 5.6. Analytical Devices
    • 5.6.1. Cell Counters
    • 5.6.2. Spectrometers
    • 5.6.3. Others

6. Microbiology Culture Market, By Culture Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 6.1.2. Market Attractiveness Index, By Culture Type
  • 6.2. Eukaryotic Culture*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Bacterial Culture

7. Microbiology Culture Market, By Consistency

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 7.1.2. Market Attractiveness Index, By Consistency
  • 7.2. Liquid Media*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Solid Culture Media
  • 7.4. Semi-solid Media

8. Microbiology Culture Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Pharmaceuticals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Food & Beverage Industry
  • 8.4. Water Testing
  • 8.5. Cosmetics

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Merck KGaA*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Yokogawa Electric Corporation
  • 10.3. SATAKE MultiMix Corporation
  • 10.4. B.E.MARUBISHI CO., LTD.
  • 10.5. ABLE Corporation & Biott Corporation
  • 10.6. Eiken Chemical co. Lti.
  • 10.7. BioMerieux S.A.
  • 10.8. Thermo Fisher Scientific, Inc.
  • 10.9. Sartorius AG
  • 10.10. Kerry Group plc.

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us